DOH Health Advisory: Recommendations to Resume Use of the Janssen/Johnson & Johnson COVID-19 Vaccine

DOH has issued recommendations for resuming use of the Janssen/Johnson & Johnson COVID-19 vaccine. The document outlines considerations for the use of the vaccine in certain populations and warns of possible adverse effects to monitor and report.
The advisory should be distributed to all personnel conducting medical screening and evaluation, vaccine administration, pharmacists, specialists, and all primary care providers.

DOH COVID-19 Policy for Use of Predrawn Vaccine for Homebound, Nursing Homes and Adult Care Facilities

CDC has